Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metasta...
Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement
About this item
Full title
Author / Creator
Salaun, Pierre-Yves , Campion, Loïc , Bournaud, Claire , Faivre-Chauvet, Alain , Vuillez, Jean-Philippe , Taieb, David , Ansquer, Catherine , Rousseau, Caroline , Borson-Chazot, Françoise , Bardet, Stéphane , Oudoux, Aurore , Cariou, Bertrand , Mirallié, Eric , Chang, Chien-Hsing , Sharkey, Robert M , Goldenberg, David M , Chatal, Jean-François , Barbet, Jacques and Kraeber-Bodéré, Françoise
Publisher
United States: Society of Nuclear Medicine
Journal title
Language
English
Formats
Publication information
Publisher
United States: Society of Nuclear Medicine
Subjects
More information
Scope and Contents
Contents
The prognosis of medullary thyroid carcinoma (MTC) varies from long- to short-term survival based on such prognostic factors as serum calcitonin and carcinoembryonic antigen (CEA) doubling times (DTs). This prospective phase II multicenter trial evaluated the efficacy and safety of anti-CEA pretargeted radioimmunotherapy (pRAIT) in rapidly progress...
Alternative Titles
Full title
Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement
Authors, Artists and Contributors
Author / Creator
Campion, Loïc
Bournaud, Claire
Faivre-Chauvet, Alain
Vuillez, Jean-Philippe
Taieb, David
Ansquer, Catherine
Rousseau, Caroline
Borson-Chazot, Françoise
Bardet, Stéphane
Oudoux, Aurore
Cariou, Bertrand
Mirallié, Eric
Chang, Chien-Hsing
Sharkey, Robert M
Goldenberg, David M
Chatal, Jean-François
Barbet, Jacques
Kraeber-Bodéré, Françoise
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_hal_00932253v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_00932253v1
Other Identifiers
ISSN
0161-5505
E-ISSN
1535-5667,2159-662X
DOI
10.2967/jnumed.111.101865
